By attending the 2nd Annual Global Vaccine Forum you will find the answers on the most challenging questions that will be shaping the vaccine’s market in upcoming years.

Benefit from understanding:

• Which developing world needs have stayed still unmet?
• Development of influenza vaccines – What are the main technical and regulatory aspects to consider?
• How to acquire best collaboration practices?
• How much to invest in biodefense?
• Which are the crucial knowledge when it comes to combination vaccines?
• Is there a way how to overcome market access barriers?
• What is the position of HPV vaccines and allergy vaccines on the market in 2012?
• What are the critical issues in the cancer vaccine development?

This is just a short list of questions to be answered by 20+ opinion leaders from Sanofi Pasteur, European Vaccine Initiative, Health Protection Agency, Merck & Co., Serum Institute of India, Novartis Vaccines & Diagnostics and others.

This year’s special features:

• Pre-conference workshop focused on the recent concerns in the immunization against seasonal and pandemic influenza virus and development of combined norovirus-rotavirus vaccine
  
• Vaccine lifecycle – closer look at the different stages
• Special insight into the recent developments in cancer vaccines from GSK, Takeda and Genticel perspective